In today’s recent session, 50.59 million shares of the NKGen Biotech Inc (NASDAQ:NKGN) have been traded, and its beta is 0.48. Most recently the company’s share price was $0.48, and it changed around $0.1 or 25.57% from the last close, which brings the market valuation of the company to $21.43M. NKGN at last check was trading at a discount to its 52-week high of $4.06, offering almost -745.83% off that amount. The share price’s 52-week low was $0.20, which indicates that the recent value has risen by an impressive 58.33% since then. We note from NKGen Biotech Inc’s average daily trading volume that its 10-day average is 0.11 million shares, with the 3-month average coming to 531.18K.

NKGen Biotech Inc (NASDAQ:NKGN) trade information

Instantly NKGN has been showing a green trend so far today with a performance of 25.57% on intraday trading today. The performance over the last five days has remained in the green territory. The rise to weekly highs of 0.6413 on recent trading dayincreased the stock’s daily price by 25.15%. The company’s shares are currently down -27.21% year-to-date, but still up 3.05% over the last five days. On the other hand, NKGen Biotech Inc (NASDAQ:NKGN) is -2.67% down in the 30-day period. We can see from the shorts that 0.52 million shares have been sold at a short interest cover period of 2.3 day(s).

NKGen Biotech Inc (NASDAQ:NKGN)’s Major holders

Upon looking at major shareholders, it appears that insiders hold 39.40% of NKGen Biotech Inc shares, and 17.26% of them are in the hands of institutional investors. The stock currently has a share float of 28.48%.

Vanguard Total Stock Market Index Fund and Fidelity Extended Market Index Fund were the top two Mutual Funds as of Sep 30, 2024. The former held 174.0 shares worth $83519.0, making up 0.39% of all outstanding shares. On the other hand, Fidelity Extended Market Index Fund held roughly 67.25 shares worth around $32279.0, which represents about 0.15% of the total shares outstanding.